JP2013513607A5 - - Google Patents

Download PDF

Info

Publication number
JP2013513607A5
JP2013513607A5 JP2012543187A JP2012543187A JP2013513607A5 JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5 JP 2012543187 A JP2012543187 A JP 2012543187A JP 2012543187 A JP2012543187 A JP 2012543187A JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
salt
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013513607A (ja
JP5631411B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/059158 external-priority patent/WO2011071840A1/en
Publication of JP2013513607A publication Critical patent/JP2013513607A/ja
Publication of JP2013513607A5 publication Critical patent/JP2013513607A5/ja
Application granted granted Critical
Publication of JP5631411B2 publication Critical patent/JP5631411B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543187A 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤 Expired - Fee Related JP5631411B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28531709P 2009-12-10 2009-12-10
US61/285,317 2009-12-10
PCT/US2010/059158 WO2011071840A1 (en) 2009-12-10 2010-12-07 Inhibitors of diacylglycerol acyltransferase

Publications (3)

Publication Number Publication Date
JP2013513607A JP2013513607A (ja) 2013-04-22
JP2013513607A5 true JP2013513607A5 (US06780888-20040824-C00057.png) 2013-11-21
JP5631411B2 JP5631411B2 (ja) 2014-11-26

Family

ID=43569741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543187A Expired - Fee Related JP5631411B2 (ja) 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤

Country Status (14)

Country Link
US (1) US8299061B2 (US06780888-20040824-C00057.png)
EP (1) EP2509981B1 (US06780888-20040824-C00057.png)
JP (1) JP5631411B2 (US06780888-20040824-C00057.png)
KR (1) KR101395428B1 (US06780888-20040824-C00057.png)
CN (1) CN102666543B (US06780888-20040824-C00057.png)
AR (1) AR079170A1 (US06780888-20040824-C00057.png)
AU (1) AU2010328410B2 (US06780888-20040824-C00057.png)
BR (1) BR112012013918A2 (US06780888-20040824-C00057.png)
CA (1) CA2783684C (US06780888-20040824-C00057.png)
EA (1) EA020128B1 (US06780888-20040824-C00057.png)
ES (1) ES2509922T3 (US06780888-20040824-C00057.png)
MX (1) MX2012006646A (US06780888-20040824-C00057.png)
TW (1) TWI392680B (US06780888-20040824-C00057.png)
WO (1) WO2011071840A1 (US06780888-20040824-C00057.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011278927B2 (en) 2010-07-16 2015-05-21 Abbvie Ireland Unlimited Company Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
NZ605471A (en) 2010-07-16 2015-02-27 Abbvie Bahamas Ltd Phosphine ligands for catalytic reactions
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2015120610A1 (en) * 2014-02-14 2015-08-20 Eli Lilly And Company Gpr142 agonist compound
CN105153195B (zh) * 2015-09-01 2017-09-26 汤文建 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
JP7299350B2 (ja) * 2019-05-31 2023-06-27 メッドシャイン ディスカバリー インコーポレイテッド Rip-1キナーゼ阻害剤としての二環式化合物およびその使用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847248A (en) 1986-12-23 1989-07-11 Merck & Co., Inc. 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
US4735941A (en) 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
EP0272866A1 (en) 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
CA2071092A1 (en) 1991-06-14 1992-12-15 Roger M. Freidinger 1,4-benzodiazepines with 5-membered heterocyclic rings
DK0730581T3 (da) 1993-11-22 2001-11-26 Merck & Co Inc 3-acylaminobezazepiner
US5439906A (en) 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
WO1995014694A1 (en) 1993-11-22 1995-06-01 Merck & Co., Inc. Benzodiazepines
US5834464A (en) 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
EA002100B1 (ru) 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
EP1784390A2 (en) * 2004-08-13 2007-05-16 Amgen Inc. Substituted benzofused heterocycles
JP2008540485A (ja) * 2005-05-10 2008-11-20 エフ.ホフマン−ラ ロシュ アーゲー ジアシルグリセロールアシルトランスフェラーゼ阻害剤
CA2615463A1 (en) 2005-07-29 2007-02-08 Merck & Co., Inc. Heterocyclic benzodiazepine cgrp receptor antagonists
US7569590B2 (en) 2006-09-19 2009-08-04 Bristol-Myers Squibb Company Use of thianecarboxamides as dgat inhibitors
US8394823B2 (en) 2008-04-11 2013-03-12 Bristol-Myers Squibb Company Triazolopyridine compounds useful as DGAT1 inhibitors
WO2009126624A1 (en) 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolo compounds useful as dgat1 inhibitors
JP2010116364A (ja) 2008-11-14 2010-05-27 Banyu Pharmaceut Co Ltd アゼピノン誘導体
US20110319396A1 (en) 2009-01-23 2011-12-29 Msd K.K. Benzodiazepin-2-on derivatives
JP2012517997A (ja) 2009-02-17 2012-08-09 Msd株式会社 1,4−ベンゾジアゼピン−2−オン誘導体

Similar Documents

Publication Publication Date Title
JP2013507423A5 (US06780888-20040824-C00057.png)
JP2013513607A5 (US06780888-20040824-C00057.png)
JP2012506896A5 (US06780888-20040824-C00057.png)
JP2013032389A5 (US06780888-20040824-C00057.png)
JP2010536766A5 (US06780888-20040824-C00057.png)
JP2014500861A5 (US06780888-20040824-C00057.png)
JP2013508279A5 (US06780888-20040824-C00057.png)
JP2011105738A5 (US06780888-20040824-C00057.png)
JP2012502037A5 (US06780888-20040824-C00057.png)
JP2013518107A5 (US06780888-20040824-C00057.png)
JP2012092103A5 (US06780888-20040824-C00057.png)
JP2010077141A5 (US06780888-20040824-C00057.png)
JP2016006118A5 (US06780888-20040824-C00057.png)
JP2015024998A5 (US06780888-20040824-C00057.png)
JP2015505296A5 (US06780888-20040824-C00057.png)
JP2009535462A5 (US06780888-20040824-C00057.png)
JP2013542247A5 (US06780888-20040824-C00057.png)
JP2010501534A5 (US06780888-20040824-C00057.png)
JP2013537203A5 (US06780888-20040824-C00057.png)
JP2011527299A5 (US06780888-20040824-C00057.png)
JP2015516427A5 (US06780888-20040824-C00057.png)
JP2012532883A5 (US06780888-20040824-C00057.png)
JP2014507477A5 (US06780888-20040824-C00057.png)
JP2007302689A5 (US06780888-20040824-C00057.png)
JP2012512863A5 (US06780888-20040824-C00057.png)